Login
$AGL
$116.75 +$0.00 (0.0%) After hours

$AGL 8-K SEC Filings

Filed On Filing
04 Nov 2026 8-K: Results of Operations and Financial Condition

Westerville, O.H., November 4, 2026 – agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2026.

05 Aug 2026 8-K: Results of Operations and Financial Condition

Westerville, O.H., August 5, 2026 – agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the second quarter ended June 30, 2026. In addition, ...

22 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

This Severance Agreement and General Release (“Agreement”) is between agilon health, inc. (“Company”) and Girish Venkatachaliah (“Employee”).

03 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On June 2, 2026, agilon health, inc. (the "Company") held its annual meeting of stockholders (the “Annual Meeting”). Below are the final voting results.

06 May 2026 8-K: Results of Operations and Financial Condition

Westerville, O.H., May 6, 2026 – agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the first quarter ended March 31, 2026. In addition, the...

27 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Healthcare industry veteran with more than 25 years of payor, provider and value-based care leadership to lead agilon’s next chapter

30 Mar 2026 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year

agilon health, inc., a corporation having a date of incorporation of April 21, 2017, and duly organized and existing under the General Corporation Law of the State of Delaware (the "Corporation"), hereby certifies as follows:

18 Mar 2026 8-K: Submission of Matters to a Vote of Security Holders; Other Events

WESTERVILLE, Ohio, March 18, 2026--(BUSINESS WIRE)-- agilon health, inc. (NYSE: AGL) (the “Company”), the trusted partner empowering physicians to transform health care in our communities, today announced that it will implement a reverse...

25 Feb 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Westerville, O.H., February 25, 2026 – agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the fourth quarter and fiscal year ended December ...

12 Feb 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

THIRD AMENDMENT TO CREDIT AGREEMENT, dated as of February 12, 2026 (this

07 Jan 2026 8-K: Departure/Election of Directors or Officers; Compensation

On December 31, 2025, agilon health, inc. (the “Company”) entered into an Amended and Restated Employment Agreement with Jeffrey Schwaneke, the Company’s Chief Financial Officer and Executive Vice President (the “Amended Employment Agree...

07 Nov 2025 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure

Westerville, Ohio, November 7, 2025 – agilon health, inc. (the “Company”) (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that the New York Stock Exchange (the “NYSE”) i...

04 Nov 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Continued Progress on Transformation Initiatives Including the Execution of $30 million in 2026 Operating Cost Reductions

04 Aug 2025 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +2 more

Section 1.03. Participation in Meetings by Remote Communication 2

30 May 2025 8-K: Submission of Matters to a Vote of Security Holders

On May 28, 2025, agilon health, inc. (the "Company") held its annual meeting of stockholders (the “Annual Meeting”). Below are the final voting results.

06 May 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Westerville, O.H., May 6, 2025 – agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the first quarter ended March 31, 2025.

25 Feb 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Medicare Advantage membership increased 36% to 527,000, and total members on the agilon platform grew to 659,000 as of December 31, 2024

05 Dec 2024 8-K: Entry into a Material Definitive Agreement; Other Events

This Indemnification Agreement (“Agreement”) is made as of ______________, 2024 by and between agilon health, inc., a Delaware corporation (the “Company”), and [Board Director Name] ("Indemnitee"). This Agreement supersedes and replaces ...

19 Nov 2024 8-K: Regulation FD Disclosure

November 19, 2024 Wolfe Investor Presentation Copyright © 2024 agilon health

07 Nov 2024 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Revenue increased 28% to $1.45 billion, Medicare Advantage membership increased 37% to 525,000, and total members on the agilon platform grew 39% to 657,000

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support